MAPT and Alzheimer disease: A bidirectional hypothesis between sleep disorder and AD progression was recently proposed, in which sleep disorder mutually interacts with AD‐related pathophysiological biomarkers, such as amyloid‐β (Aβ) and hyperphosphorylated tau protein (p‐tau).7, 8